Improving the lives of our patients.
We work tirelessly to create life changing treatments that help our patients live better and fuller lives.Learn More
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patientsLearn More
During #NationalCancerControlMonth, we recognize that while progress has been made in the fight against cancer, much work remains. At Servier, we are committed to preventing cancer and improving treatment options for patients.Learn More
Today, our Global Head of M&A and Venture Investments joins @ldtimmerman alongside a team of oncology patients, survivors and industry leaders to advance cancer research in the hike to Everest Base Camp!Learn More
Servier Announces FDA Filing Acceptance and Priority Review for TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Previously Untreated IDH1-mutated Acute Myeloid LeukemiaLearn More
Adobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business